These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 10411470)

  • 1. Ecteinascidin 743: a minor groove alkylator that bends DNA toward the major groove.
    Zewail-Foote M; Hurley LH
    J Med Chem; 1999 Jul; 42(14):2493-7. PubMed ID: 10411470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antitumor agent ecteinascidin 743: characterization of its covalent DNA adducts and chemical stability.
    Hurley LH; Zewail-Foote M
    Adv Exp Med Biol; 2001; 500():289-99. PubMed ID: 11764956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inefficiency of incisions of ecteinascidin 743-DNA adducts by the UvrABC nuclease and the unique structural feature of the DNA adducts can be used to explain the repair-dependent toxicities of this antitumor agent.
    Zewail-Foote M; Li VS; Kohn H; Bearss D; Guzman M; Hurley LH
    Chem Biol; 2001 Nov; 8(11):1033-49. PubMed ID: 11731295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata.
    Pommier Y; Kohlhagen G; Bailly C; Waring M; Mazumder A; Kohn KW
    Biochemistry; 1996 Oct; 35(41):13303-9. PubMed ID: 8873596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential rates of reversibility of ecteinascidin 743-DNA covalent adducts from different sequences lead to migration to favored bonding sites.
    Zewail-Foote M; Hurley LH
    J Am Chem Soc; 2001 Jul; 123(27):6485-95. PubMed ID: 11439034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poisoning of human DNA topoisomerase I by ecteinascidin 743, an anticancer drug that selectively alkylates DNA in the minor groove.
    Takebayashi Y; Pourquier P; Yoshida A; Kohlhagen G; Pommier Y
    Proc Natl Acad Sci U S A; 1999 Jun; 96(13):7196-201. PubMed ID: 10377391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioselective synthesis of saframycin A and evaluation of antitumor activity relative to ecteinascidin/saframycin hybrids.
    Martinez EJ; Corey EJ
    Org Lett; 1999 Jul; 1(1):75-7. PubMed ID: 10822537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic studies on ecteinascidin-743: constructing a versatile pentacyclic intermediate for the synthesis of ecteinascidins and saframycins.
    Jin W; Metobo S; Williams RM
    Org Lett; 2003 Jun; 5(12):2095-8. PubMed ID: 12790537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA structural similarity in the 2:1 complexes of the antitumor drugs trabectedin (Yondelis) and chromomycin A3 with an oligonucleotide sequence containing two adjacent TGG binding sites on opposing strands.
    Marco E; Gago F
    Mol Pharmacol; 2005 Dec; 68(6):1559-67. PubMed ID: 16150929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 3.(ET743)-DNA complex that both resembles an RNA-DNA hybrid and mimicks zinc finger-induced DNA structural distortions.
    Marco E; García-Nieto R; Mendieta J; Manzanares I; Cuevas C; Gago F
    J Med Chem; 2002 Feb; 45(4):871-80. PubMed ID: 11831898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further insight into the DNA recognition mechanism of trabectedin from the differential affinity of its demethylated analogue ecteinascidin ET729 for the triplet DNA binding site CGA.
    Marco E; David-Cordonnier MH; Bailly C; Cuevas C; Gago F
    J Med Chem; 2006 Nov; 49(23):6925-9. PubMed ID: 17154523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ecteinascidin-743.
    Held-Warmkessel J
    Clin J Oncol Nurs; 2003; 7(3):313-9. PubMed ID: 12793338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potent anticancer compound ecteinascidin-743 (ET-743) as its 2-propanol disolvate.
    Sainz-Diaz CI; Manzanares I; Francesch A; Garcia-Ruiz J
    Acta Crystallogr C; 2003 Apr; 59(Pt 4):O197-8. PubMed ID: 12682407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ecteinascidin 743 induces protein-linked DNA breaks in human colon carcinoma HCT116 cells and is cytotoxic independently of topoisomerase I expression.
    Takebayashi Y; Goldwasser F; Urasaki Y; Kohlhagen G; Pommier Y
    Clin Cancer Res; 2001 Jan; 7(1):185-91. PubMed ID: 11205907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ecteinascidin 743: a novel anticancer drug with a unique mechanism of action.
    Aune GJ; Furuta T; Pommier Y
    Anticancer Drugs; 2002 Jul; 13(6):545-55. PubMed ID: 12172500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and cytotoxic evaluation of some cribrostatin-ecteinascidin analogues.
    Wright BJ; Chan C; Danishefsky SJ
    J Nat Prod; 2008 Mar; 71(3):409-14. PubMed ID: 18278868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased DNA binding specificity for antitumor ecteinascidin 743 through protein-DNA interactions?
    García-Nieto R; Manzanares I; Cuevas C; Gago F
    J Med Chem; 2000 Nov; 43(23):4367-9. PubMed ID: 11087561
    [No Abstract]   [Full Text] [Related]  

  • 18. Phthalascidin, a synthetic antitumor agent with potency and mode of action comparable to ecteinascidin 743.
    Martinez EJ; Owa T; Schreiber SL; Corey EJ
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3496-501. PubMed ID: 10097064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ET-743 (PharmaMar/NCI/Ortho Biotech).
    Verschraegen CF; Glover K
    Curr Opin Investig Drugs; 2001 Nov; 2(11):1631-8. PubMed ID: 11763168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trabectedin: ET 743, ecteinascidin 743, Yondelis.
    Drugs R D; 2003; 4(1):75-81. PubMed ID: 12568645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.